Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in patients with B-cell...
Pirtobrutinib shows promising safety and activity among patients with Richter transformation, most of whom received previous Richter transformation-directed therapy, including covalent BTK inhibito...
thelancet.com